|
[1]
|
Lafeber, F.P.J.G., Schaefer, H.I.M.B., Herrmann-Erlee, M.P.M. and Wendelaar Bonga, S.E. (1986) Parathyroid Hormone-Like Effects of Rainbow-Trout Stannius Products on Bone-Resorption of Embryonic Mouse Calvaria in Vitro. Endocrinology, 119, 2249-2255. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chang, A.C.M., Janosi, J., Hulsbeek, M., et al. (1995) A Novel Human cDNA Highly Homologous to the Fish Hormone Stanniocalcin. Molecular and Cellular Endocrinology, 112, 241-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chang, A.C.M., Dunham, M.A., Jeffrey, K.J. and Reddel, R.R. (1996) Molecular Cloning and Characterization of Mouse Stanniocalcin cDNA. Molecular and Cellular Endocrinology, 124, 185-187. [Google Scholar] [CrossRef]
|
|
[4]
|
Ishibashi, K., Miyamoto, K., Taketani, Y., et al. (1998) Molecular Cloning of a Second Human Stanniocalcin Homologue (STC2). Biochemical and Biophysical Research Communications, 250, 252-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
White, K.E., Biber, J., Murer, H. and Econs, M.J. (1998) Chromosomal Localization of Two Human Genes Involved in Phosphate Homeostasis: The Type IIb Sodium-Phosphate Cotransporter and Stanniocalcin-2. Somatic Cell and Molecular Genetics, 24, 357-362.
|
|
[6]
|
李伟, 周蒙, 董秋萍, 等. 人STC2蛋白的生物学分析[J]. 基因组学与应用生物学, 2018, 37(11): 5138-5145.
|
|
[7]
|
Ito, D., Walker, J.R., Thompson, C.S., et al. (2004) Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties. Molecular and Cellular Biology, 24, 9456-9469.
|
|
[8]
|
Moore, E.E., Kuestner, R.E., Conklin, D.C., et al. (1999) Stanniocalcin 2: Characterization of the Protein and Its Localization to Human Pancreatic Alpha Cells. Hormone and Metabolic Research, 31, 406-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Beale, E.G., Harvey, B.J. and Forest, C, (2007) PCK1 and PCK2 as Candidate Diabetes and Obesity Genes. Cell Biochemistry and Biophysics, 48, 89-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
De Souza, S.K., Sarapio, E., Vogt, E.L., et al. (2020) Effects of Stanniocalcin Hormones on Rat Hepatic Glucose Homeostasis under Fed and Fasted Conditions. General and Comparative Endocrinology, 302, Article ID: 113661.
|
|
[11]
|
Jiao, Y., et al. (2017) Stanniocalcin 2 Acts as an Anorectic Factor through Activation of STAT3 Pathway. Oncotarget, 8, 91067-91075. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Joshi, A.D., Carter, D.E., Harper Jr., T.A. and Elferink, C.J. (2015) Aryl Hydrocarbon Receptor-Dependent Stanniocalcin 2 Induction by Cinnabarinic Acid Provides Cytoprotection against Endoplasmic Reticulum and Oxidative Stress. Journal of Pharmacology and Experimental Therapeutics, 353, 201-212. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhao, J., Jiao, Y., Song, Y., et al. (2018) Stanniocalcin 2 Ameliorates Hepatosteatosis through Activation of STAT3 Signaling. Frontiers in Physiology, 9, Article No. 873.
|
|
[14]
|
陶文玉, 陈郊丽, 李晓进. 等. 斯钙素2在高糖诱导的肝细胞炎症反应中的作用机制[J]. 实用医学杂志, 2019, 35(14): 2220-2224+2229.
|
|
[15]
|
Ueki, K., Kondo, T., Tseng, Y.H. and Kahn, C.R. (2004) Central Role of Suppressors of Cytokine Signaling Proteins in Hepatic Steatosis, Insulin Resistance, and the Metabolic Syndrome in the Mouse. Proceedings of the National Academy of Sciences of the United States of America, 101, 10422-10427. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Panagiotou, G., Anastasilakis, A.D., Kynigopoulos, G., et al. (2017) Physiological Parameters Regulating Circulating Levels of the IGFBP-4/Stanniocalcin-2/PAPP-A Axis. Metabolism, 75, 16-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Hjortebjerg, R., et al. (2018) Depot-Specific and GH-Dependent Regulation of IGF Binding Protein-4, Pregnancy-Associated Plasma Protein-A, and Stanniocalcin-2 in Murine Adipose Tissue. Growth Hormone & IGF Research, 39, 54-61. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sarapio, E., De Souza, S.K., Model, J.F.A., et al. (2019) Stanniocalcin-1 and -2 Effects on Glucose and Lipid Metabolism in White Adipose Tissue from Fed and Fasted Rats. Canadian Journal of Physiology and Pharmacology, 97, 916-923. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zeiger, W., et al. (2011) Stanniocalcin 2 Is a Negative Modulator of Store-Operated Calcium Entry. Molecular and Cellular Biology, 31, 3710-3722.
|
|
[20]
|
Sarapio, E., et al. (2019) Effects of Stanniocalcin Hormones on Rat Brown Adipose Tissue Metabolism under Fed and Fasted Conditions. Molecular and Cellular Endocrinology, 485, 81-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Chang, A.C.M., Hook, J., Lemckert, F.A., et al. (2007) The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth. Endocrinology, 149, 2403-2410.
|
|
[22]
|
Gagliardi, A.D., et al. (2005) Human Stanniocalcin-2 Exhibits Potent Growth-Suppressive Properties in Transgenic Mice Independently of Growth Hormone and IGFs. American Journal of Physiology-Endocrinology and Metabolism, 288, E92-E105. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Johnston, J., Ramos-Valdes, Y., Stanton, L.A., et al. (2010) Human Stanniocalcin-1 or -2 Expressed in Mice Reduces Bone Size and Severely Inhibits Cranial Intramembranous Bone Growth. Transgenic Research, 19, 1017-1039.
|
|
[24]
|
Oxvig, C. (2015) The Role of PAPP-A in the IGF System: Location, Location, Location. Journal of Cell Communication and Signaling, 9, 177-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Cordero, A.I.H., et al. (2019) Genome-Wide Associations Reveal Human-Mouse Genetic Convergence and Modifiers of Myogenesis, CPNE1 and STC2. The American Journal of Human Genetics, 105, 1222-1236.
|
|
[26]
|
Rubin, H. (2003) Cancer Cachexia: Its Correlations and Causes. Proceedings of the National Academy of Sciences of the United States of America, 100, 5384-5389. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
López, J.J., Jardín, I., Chamorro, C.C., et al. (2018) Involvement of Stanniocalcins in the Deregulation of Glycaemia in Obese Mice and Type 2 Diabetic Patients. Journal of Cellular and Molecular Medicine, 22, 684-694.
|
|
[28]
|
Fazio, E.N., et al. (2011) Stanniocalcin 2 Alters PERK Signalling and Reduces Cellular Injury during Cerulein Induced Pancreatitis in Mice. BMC Cell Biology, 12, Article No. 17.
|
|
[29]
|
Wang, H., et al. (2012) STC2 Is Upregulated in Hepatocellular Carcinoma and Promotes Cell Proliferation and Migration in Vitro. BMB Reports, 45, 629-634. [Google Scholar] [CrossRef]
|
|
[30]
|
Yang, S., Ji, Q., Chang, B., et al. (2017) STC2 Promotes Head and Neck Squamous Cell Carcinoma Metastasis through Modulating the PI3K/AKT/Snail Signaling. Oncotarget, 8, 5976-5991. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kim, P.H., et al. (2015) Stanniocalcin 2 Enhances Mesenchymal Stem Cell Survival by Suppressing Oxidative Stress. BMB Reports, 48, 702-707. [Google Scholar] [CrossRef]
|
|
[32]
|
Liu, Y.N., et al. (2019) Acquired Resistance to EGFR Tyrosine Kinase Inhibitors Is Mediated by the Reactivation of STC2/JUN/AXL Signaling in Lung Cancer. International Journal of Cancer, 145, 1609-1624. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Joensuu, K., Heikkilä, P. and Andersson, L.C. (2008) Tumor Dormancy: Elevated Expression of Stanniocalcins in Late Relapsing Breast Cancer. Cancer Letters, 265, 76-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Hou, J., et al. (2015) Stanniocalicin 2 Suppresses Breast Cancer Cell Migration and Invasion via the PKC/Claudin-1- Mediated Signaling. PLoS ONE, 10, e0122179. [Google Scholar] [CrossRef] [PubMed]
|